Göran Forsberg

Göran Forsberg is currently the Chief Executive Officer at Cantargia AB since 2014 and an Independent Director at Guard Therapeutics International AB since 2019.
He previously held positions as a Non-Executive Director at Isogenica Ltd., Director at Active Security Trading AB, Director at Active Biotech Research AB, Director at Actinova AB, Vice President-Investor Relations at Active Biotech AB from 1998 to 2011, and Head of Business Development & Investor Relations at both the University of Adelaide and Kabigen AB.